Industry NewsPhase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
Industry NewsNirsevimab reduced respiratory syncytial virus infections and hospitalizations in preterm infants in Phase IIb trial
Industry NewsAstraZeneca, Oxford University COVID-19 vaccine shows robust immune responses in Phase I/II trial
Industry NewsAstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine
